These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1832993)

  • 1. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
    Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
    Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
    Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
    Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells.
    Schwinzer R; Schlitt HJ; Wonigeit K
    Cell Immunol; 1992 Mar; 140(1):31-41. PubMed ID: 1531453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 pathway of T-cell activation. II. Role of HLA-class I molecules in early events.
    Schwab R; Weksler ME; Russo C
    Cell Immunol; 1988 Sep; 115(2):310-24. PubMed ID: 2457448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
    Oshima S; Eckels DD
    J Immunol; 1990 Dec; 145(12):4018-25. PubMed ID: 1979584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of expression of interleukin 2 receptors upon triggering of the TCR-CD3 complex on human T lymphocytes.
    Kabouridis PS; Tsoukas CD
    Immunol Invest; 1990 Aug; 19(4):385-401. PubMed ID: 2145219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
    Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
    Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilized anti-CD3-induced T cell growth: comparison of the frequency of responding cells within various T cell subsets.
    Geppert TD; Lipsky PE
    Cell Immunol; 1991 Mar; 133(1):206-18. PubMed ID: 1703926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of aggregating the CD3 molecular complex on T cell activation.
    Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE
    Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
    Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
    Panzer S; Geller RL; Bach FH
    Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of CD7+, CD3+, and CD8+ lymphocytes from first trimester human decidua using two-color flow cytometry.
    Chernyshov VP; Slukvin II; Bondarenko GI
    Am J Reprod Immunol; 1993 Jan; 29(1):5-16. PubMed ID: 7684920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of thymocyte proliferation by alpha beta TcR+ CD3+ CD4- CD8- cloned natural suppressor (NS) cells.
    Van Vlasselaer P; Fischer M; Strober S; Zlotnik A
    Cell Immunol; 1991 Aug; 136(1):1-15. PubMed ID: 1829396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
    Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
    Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice.
    Hertogh-Huijbregts A; Vissinga C; Rozing J; Nagelkerken L
    Mech Ageing Dev; 1990 Apr; 53(2):141-55. PubMed ID: 1971316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.